Please use this identifier to cite or link to this item:
https://olympias.lib.uoi.gr/jspui/handle/123456789/22034| Title: | Efficacy and safety of switching from infliximab to adalimumab: a comparative controlled study |
| Institution and School/Department of submitter: | Πανεπιστήμιο Ιωαννίνων. Σχολή Επιστημών Υγείας. Τμήμα Ιατρικής |
| Keywords: | Aged,Antibodies, Monoclonal/*administration & dosage/adverse effects/therapeutic use,Antibodies, Monoclonal, Humanized,Antirheumatic Agents/*administration & dosage/adverse effects/therapeutic use,Arthritis, Rheumatoid/*drug therapy/immunology/physiopathology,Blood Sedimentation,C-Reactive Protein/analysis,Drug Administration Schedule,Female,Health Status Indicators,Humans,Joints/physiopathology,Male,Middle Aged,Platelet Count,Treatment Outcome,Tumor Necrosis Factor-alpha/antagonists & inhibitors |
| URI: | https://olympias.lib.uoi.gr/jspui/handle/123456789/22034 |
| ISSN: | 0003-4967 |
| Link: | http://www.ncbi.nlm.nih.gov/pubmed/15975964 http://ard.bmj.com/content/65/2/257 |
| Appears in Collections: | Άρθρα σε επιστημονικά περιοδικά ( Ανοικτά) |
Files in This Item:
| File | Description | Size | Format | |
|---|---|---|---|---|
| Drosos-2006-efficacy and safety.pdf | 500.59 kB | Adobe PDF | View/Open Request a copy |
This item is licensed under a Creative Commons License
